Aldara for the Treatment of Large and/or Multiple sBCC

Clinical trial NCT00189280 · COMPLETED

Trial details

NCT number: NCT00189280
Sponsor: MEDA Pharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Basal Cell

Start date: 2003-05-01
Primary completion: 2007-10-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.